share_log

Context Therapeutics Says On Jan. 24 Co. Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq

Context Therapeutics Says On Jan. 24 Co. Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq

Context Therapeutics 于 1 月 24收到了纳斯达克的退市或未能满足持续上市规则或标准的通知
Benzinga Real-time News ·  2023/01/27 16:06

Context Therapeutics Says On Jan. 24 Co. Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq

Context Therapeutics 于 1 月 24收到了纳斯达克的退市或未能满足持续上市规则或标准的通知

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发